Moderna reports early signs of progress during phase 1 Covid-19 vaccine trial

Moderna’s closely watched early-stage human trial for a coronavirus vaccine produced Covid-19 antibodies in all 45 participants, the biotech company announced Monday. CNBC's Meg Tirrell reports.